181 related articles for article (PubMed ID: 21775555)
1. Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.
Tao MH; Marian C; Nie J; Ambrosone C; Krishnan SS; Edge SB; Trevisan M; Shields PG; Freudenheim JL
Am J Clin Nutr; 2011 Sep; 94(3):831-8. PubMed ID: 21775555
[TBL] [Abstract][Full Text] [Related]
2. Alcohol consumption in relation to aberrant DNA methylation in breast tumors.
Tao MH; Marian C; Shields PG; Nie J; McCann SE; Millen A; Ambrosone C; Hutson A; Edge SB; Krishnan SS; Xie B; Winston J; Vito D; Russell M; Nochajski TH; Trevisan M; Freudenheim JL
Alcohol; 2011 Nov; 45(7):689-99. PubMed ID: 21168302
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of E-cadherin, p16, and RAR-β(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism.
Tao MH; Mason JB; Marian C; McCann SE; Platek ME; Millen A; Ambrosone C; Edge SB; Krishnan SS; Trevisan M; Shields PG; Freudenheim JL
Nutr Cancer; 2011; 63(7):1143-50. PubMed ID: 21916701
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
Tao MH; Shields PG; Nie J; Millen A; Ambrosone CB; Edge SB; Krishnan SS; Marian C; Xie B; Winston J; Vito D; Trevisan M; Freudenheim JL
Breast Cancer Res Treat; 2009 Apr; 114(3):559-68. PubMed ID: 18463976
[TBL] [Abstract][Full Text] [Related]
5. DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.
Tao MH; Shields PG; Nie J; Marian C; Ambrosone CB; McCann SE; Platek M; Krishnan SS; Xie B; Edge SB; Winston J; Vito D; Trevisan M; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):998-1002. PubMed ID: 19240236
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
[TBL] [Abstract][Full Text] [Related]
7. Exposures in early life: associations with DNA promoter methylation in breast tumors.
Tao MH; Marian C; Shields PG; Potischman N; Nie J; Krishnan SS; Berry DL; Kallakury BV; Ambrosone C; Edge SB; Trevisan M; Winston J; Freudenheim JL
J Dev Orig Health Dis; 2013 Apr; 4(2):182-90. PubMed ID: 25054684
[TBL] [Abstract][Full Text] [Related]
8. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
9. Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.
Han D; Nie J; Bonner MR; McCann SE; Muti P; Trevisan M; Ramirez-Marrero FA; Vito D; Freudenheim JL
Int J Cancer; 2006 Dec; 119(12):2931-7. PubMed ID: 17016824
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.
Bhagat R; Kumar SS; Vaderhobli S; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 Sep; 35(9):9069-78. PubMed ID: 24913706
[TBL] [Abstract][Full Text] [Related]
11. [Promoter methylation profile in breast cancer].
Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I
Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763
[TBL] [Abstract][Full Text] [Related]
12. Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer.
McCullough LE; Collin LJ; Conway K; White AJ; Cho YH; Shantakumar S; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
BMC Cancer; 2019 Sep; 19(1):926. PubMed ID: 31533668
[TBL] [Abstract][Full Text] [Related]
13. Gene promoter methylation is associated with increased mortality among women with breast cancer.
Xu X; Gammon MD; Zhang Y; Cho YH; Wetmur JG; Bradshaw PT; Garbowski G; Hibshoosh H; Teitelbaum SL; Neugut AI; Santella RM; Chen J
Breast Cancer Res Treat; 2010 Jun; 121(3):685-92. PubMed ID: 19921426
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.
Karray-Chouayekh S; Trifa F; Khabir A; Boujelbane N; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
J Cancer Res Clin Oncol; 2010 Feb; 136(2):203-10. PubMed ID: 19657672
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.
Callahan CL; Wang Y; Marian C; Weng DY; Eng KH; Tao MH; Ambrosone CB; Nie J; Trevisan M; Smiraglia D; Edge SB; Shields PG; Freudenheim JL
Epigenetics; 2016 Sep; 11(9):643-652. PubMed ID: 27245195
[TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
18. Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age.
Van Mieghem T; Leunen K; Pochet N; De Moor B; De Smet F; Amant F; Berteloot P; Timmerman D; Vanden Bempt I; Drijkoningen R; Wildiers H; Paridaens R; Smeets A; Hendrickx W; Van Limbergen E; Christiaens MR; Vergote I; Neven P
Breast Cancer Res Treat; 2007 Nov; 106(1):127-33. PubMed ID: 17211534
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers.
Feng W; Orlandi R; Zhao N; Carcangiu ML; Tagliabue E; Xu J; Bast RC; Yu Y
BMC Cancer; 2010 Jul; 10():378. PubMed ID: 20642860
[TBL] [Abstract][Full Text] [Related]
20. Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies.
Chen GC; Chen SJ; Zhang R; Hidayat K; Qin JB; Zhang YS; Qin LQ
Obes Rev; 2016 Nov; 17(11):1167-1177. PubMed ID: 27432212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
